Cosopt Ophthalmic Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alembic Pharma gets USFDA nod for ophthalmic solution Drug firm Alembic Pharmaceuticals on Wednesday said it has received approval from the US health regulator for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, used to treat certain types of glaucoma and other causes of high pressure inside the eye. The approved product is therapeutically equivalent to the reference listed drug product (RLD) Cosopt Ophthalmic Solution, 2 percent and 0.5 percent, of Akorn Operating Company LLC. The company has received approval from the US Food and Drug Administration (USFDA) for its abbrev...

Benchmark indices ended a volatile session with strong gains on Wednesday after the Reserve Bank of India announced measures to tackle the rising second wave of COVID-19 pandemic. The Nifty managed to close above the 14,600 mark. Barring the Nifty Realty index, all sectoral indices on the NSE ended in the green. As per the provisional closing data, the S&P BSE Sensex, rallied 424.04 points or 0.88% to 48,677.82. The Nifty 50 index gained 121.35 points or 0.84% to 14,617.40. In the broader market, the S&P BSE Mid-Cap index added 1.05% while the S&P BSE Small-Cap index surged 0.77%. The market...

The drug maker received a final approval from the US drug regulator for its Abbreviated New Drug Application (ANDA) for dorzolamide hydrochloride and timolol maleate ophthalmic solution. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Cosopt Ophthalmic Solution, 2% and 0.5% of Akorn Operating Company. Dorzolamide hydrochloride and timolol maleate ophthalmic solution is a combination of dorzolamide hydrochloride carbonic anhydrase inhibitor, and timolol maleate, a beta-adrenergic receptor blocking agent, indicated for the reduction of elevated intra...